共 8 条
[1]
Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity[J] . Howard Safran,Mohan Suntharalingam,Thomas Dipetrillo,Thomas Ng,L. Austin Doyle,Mark Krasna,Angela Plette,Devon Evans,Harold Wanebo,Paul Akerman,Jeremy Spector,Nancy Kennedy,Teresa Kennedy.International Journal of Radiation Oncology, Biology, Physics . 2008 (2)
[2]
Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma[J] . Howard Safran,Thomas DiPetrillo,Paul Akerman,Thomas Ng,Devon Evans,Margaret Steinhoff,David Benton,John Purviance,Lisa Goldstein,Umadevi Tantravahi,Teresa Kennedy.International Journal of Radiation Oncology, Biology, Physics . 2007 (2)
[3]
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial[J] . George D Demetri,Allan T van Oosterom,Christopher R Garrett,Martin E Blackstein,Manisha H Shah,Jaap Verweij,Grant McArthur,Ian R Judson,Michael C Heinrich,Jeffrey A Morgan,Jayesh Desai,Christopher D Fletcher,Suzanne George,Carlo L Bello,Xin Huang,Charles M Baum,Paolo G Casali.The Lancet . 2006 (9544)
[4]
Epidermal growth factor receptorinhibitor-associated cutaneous toxicities:an evolving paradigmin clini-cal managemen〔tJ〕 .2 Lynch Jr TJ,Kim ES,Eaby B,et al. Oncologist . 2007
[5]
ABX-EGF,a fully humananti-epidermal growth factor receptor (EGFR)monoclonal antibody (mAb)inpatients with advanced cancer:phase 1 clinical results〔J〕 .2 Figlin R,Belldegrun A,Crawford J,et al. Proc Am Soc Clin Oncol . 2002
[6]
S0413:aphaseSWOG study of GW572016 (lapatinib)as first line therapy inpatients (ptwith advanced or metastatic gastric cancer〔J〕 .2 Iqbal S,Goldman B,Lenz H,Fenoglio-Preiser C,Blanke C. J Clin On-col . 2007
[7]
Efficacy results from the To-GA trial phaseⅢstudy of trastuzumab added to standard chemother-apy (CT)in firsline human epidermal growth factor receptor 2 (HER2)-positive advancegastric cancer (GC)〔J〕 .2 Van Cutsem E,Kang Y,Chung H,et al. J Clin Oncol . 2009
[8]
Phase II trial of preoperative bevacizum-ab (Bev),irinotecan (I) cisplatin (C),and radiation (RT)in e-sophageal adenocarcinoma:preliminary safety analysis〔J〕 .2 IlsonD,BainsM,RizkN,et al. J Clin On-col . 2009